Overview
Veristat is the Science-First CRO™ and Consultancy that integrates full-service clinical trial execution, regulatory affairs and safety, and strategic consulting services to rapidly advance the development, approval, and commercialization of biologics and drug therapies around the globe. With 30 years of experience solving sponsors’ unique and complex clinical, statistical, and regulatory challenges, Veristat Science-First experts deliver timely, quality-driven results with solutions that are tailored to the needs of patients, clinical trial sites, regulators, sponsor teams, and key stakeholders.
Veristat’s focus on novel drug development has led to success when handling any unknown that arises, from the simplest to most complex, across numerous therapeutic areas including rare/ultra-rare disease, oncology/hematology, and biologics. Sponsors collaborate with Veristat Science-First experts who care— like they do. It is not just business for Veristat, it’s personal.
Veristat. The Science-First CRO™ and Consultancy
Company News
Veristat Congratulates George Medicines on FDA Approval of WIDAPLIK™
Jun 19, 2025
Posted by Veristat, LLC
Veristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs Team
May 29, 2024
Posted by Veristat, LLC
